Health
India to review COVID-19 vaccines after blood clot warning – bdnews24.com
A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered…
India is currently administering AstraZenecas COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN.
The review comes after Europes drug regulator said on Wednesday it found a possible link between AstraZenecas vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccines advantages still outweighed the risks.
India is banking on vaccinations to help contain a record…
-
Business14 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts